- 英文名称
- Grazoprevir
- 分子式
- C38H50N6O9S
- 分子量
- 766.9
- 中文别名
- 格佐普韦; 格佐匹韦; (33R,35S,91R,92R,5S)-5-(叔丁基)-N-((1R,2S)-1-((环丙基磺酰基)氨基甲酰基)-2-乙烯基环丙基)-17-甲氧基-4,7-二氧基-2,8-二氧杂-6-氮杂-1(2,3)-喹诺酮类-3(3,1)-吡咯烷-9(1,2)-环丙烷环十四烷-35-甲酰胺; MK-5172; MK5172; (33R,35S,91R,92R,5S)-5-(tert-Butyl)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxamide; (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-((1R,2S)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide; (1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide
- 用途
- 作为选择性丙型肝炎病毒NS3/4a蛋白酶抑制剂，对HCV基因型1a、1B和4具有抑制活性，IC50值分别为7pM、4pM和62pM，靶点包括gt1a、gt1b等多种HCV基因型。
